Spangler, Dennis L <br/><br/>
Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models.  [electronic resource] 

 -  Clinical therapeutics  Aug 2003 
 - 2245-67 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0149-2918 
<br/><br/><label>Standard No.: </label>10.1016/s0149-2918(03)80217-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Intranasal<br/>Administration, Oral<br/>Administration, Topical<br/>Adult<br/>Aged<br/>Allergens--adverse effects<br/>Anti-Allergic Agents--administration & dosage<br/>Conjunctiva--metabolism<br/>Conjunctivitis, Allergic--drug therapy<br/>Dibenzoxepins--administration & dosage<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Mometasone Furoate<br/>Nasal Mucosa--metabolism<br/>Olopatadine Hydrochloride<br/>Ophthalmic Solutions<br/>Pregnadienediols--administration & dosage<br/>Rhinitis, Allergic, Perennial--drug therapy<br/>Tablets<br/>Terfenadine--administration & dosage<br/>Time Factors